Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
6.07% $1.050
America/New_York / 29 jan 2024 @ 15:59
FUNDAMENTALS | |
---|---|
MarketCap: | 63.03 mill |
EPS: | -0.360 |
P/E: | -2.92 |
Earnings Date: | Feb 20, 2024 |
SharesOutstanding: | 60.02 mill |
Avg Daily Volume: | 0.326 mill |
RATING 2024-01-29 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Sell | |
Return On Asset: | Sell | |
DE: | Neutral | |
P/E: | Sell | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -2.92 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.01x |
Company: PE -2.92 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
$0.462 (-56.02%) $-0.588 |
Date: 2024-02-04 |
Expected Trading Range (DAY) |
---|
$ 0.859 - 1.031 ( +/- 9.10%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-20 | Lind Global Fund Ii Lp | Buy | 12 000 | Ordinary Shares, par value NIS 0.25 per share |
2023-11-17 | Lind Global Fund Ii Lp | Buy | 42 917 | Ordinary Shares, par value NIS 0.25 per share |
2023-11-14 | Lind Global Fund Ii Lp | Buy | 72 818 | Ordinary Shares, par value NIS 0.25 per share |
2023-09-26 | Lind Global Fund Ii Lp | Buy | 5 031 200 | Ordinary Shares, par value NIS 0.25 per share |
2023-09-26 | Lind Global Fund Ii Lp | Sell | 5 031 200 | Ordinary Shares, par value NIS 0.25 per share |
INSIDER POWER |
---|
17.08 |
Last 98 transactions |
Buy: 8 181 302 | Sell: 5 120 289 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $1.050 (6.07% ) |
Volume | 0.301 mill |
Avg. Vol. | 0.326 mill |
% of Avg. Vol | 92.19 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.